Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data
Sign Up to like & getrecommendations! Published in 2019 at "BMC Cancer"
DOI: 10.1186/s12885-019-6105-3
Abstract: BackgroundThe impact of HER2-targeted therapy alone followed by the addition of chemotherapy at disease progression (PD) versus upfront combination was investigated by the SAKK 22/99 trial. The aim of this exploratory analysis of the SAKK… read more here.
Keywords: benefit; trastuzumab monotherapy; term; long term ... See more keywords
Long-term responders with metastatic breast cancer (MBC) receiving eribulin: Real life experience.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e13065
Abstract: e13065Background: Recently developed microtubule dynamics inhibitor eribulin mesylate (eribulin) differs from taxanes and vinca alkaloids by another mechanism of action. Here, we describe eribulin-... read more here.
Keywords: long term; breast cancer; term responders; metastatic breast ... See more keywords
KRASG12C/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Translational lung cancer research"
DOI: 10.21037/tlcr-20-958
Abstract: Background Pembrolizumab is a standard of care as first line palliative therapy in PD-L1 overexpressing (≥50%) non-small cell lung cancer (NSCLC). This study aimed at the identification of KRAS and TP53-defined mutational subgroups in the… read more here.
Keywords: first line; long term; term responders; tp53 mutations ... See more keywords
Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
Sign Up to like & getrecommendations! Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12907
Abstract: Background/Aim: A long-term effect has been confirmed in clinical practice since the introduction of nivolumab for treating various malignant tumors. A similar phenomenon is speculated to occur in head and neck cancer; however, details remain… read more here.
Keywords: term responders; long term; year; neck cancer ... See more keywords